04:17 AM EDT, 07/23/2025 (MT Newswires) -- Carlsmed said late Tuesday it has priced an initial public offering of 6.7 million shares at $15 each for estimated gross proceeds of about $100.5 million.

The medical technology company said its shares are expected to begin trading on the Nasdaq Global Select Market this Wednesday, under the ticker symbol "CARL." The offering is expected to close Thursday.

Carlsmed, which offers artificial intelligence-enabled personalized spine surgery, granted underwriters a 30-day option to purchase up to an additional 1 million shares.